
Home - GRAIL
May 30, 2026 · GRAIL is a healthcare company pioneering new technologies to advance early cancer detection. Discover our mission to detect cancer early, when it can be cured.
Grailed: Online Marketplace to Buy Fashion
Shop men's and women's clothing on Grailed, the platform for personal style. Explore top listings from the community today.
GRAIL Definition & Meaning - Merriam-Webster
5 days ago · The meaning of GRAIL is the cup or platter used according to medieval legend by Christ at the Last Supper and thereafter the object of knightly quests. How to use grail in a sentence.
Grail (company) - Wikipedia
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms.
Holy Grail - Wikipedia
Various traditions describe the Holy Grail as a cup, dish, or stone with miraculous healing powers, sometimes providing eternal youth or sustenance in infinite abundance, often guarded in the custody …
Our Story - GRAIL
GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and …
GRAIL (GRAL) Stock Price & Overview
2 days ago · A detailed overview of GRAIL, Inc. (GRAL) stock, including real-time price, chart, key statistics, news, and more.
Blood Test for Cancer Screening | Galleri®
The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration.
GRAIL, Inc. (GRAL) Stock Price, News, Quote & History - Yahoo Finance
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
Galleri early cancer detection blood test: I tried it. - USA TODAY
Nov 5, 2025 · Multiple companies are trying to detect cancer via blood test. But GRAIL is the one you're hearing about in the mainstream thanks to its funding of large, international prospective clinical...